US Stock MarketDetailed Quotes

CING Cingulate

Watchlist
  • 4.3000
  • -0.0500-1.15%
Close Mar 31 16:00 ET
  • 4.3700
  • +0.0700+1.63%
Pre 09:21 ET
16.20MMarket Cap-0.42P/E (TTM)

About Cingulate Company

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Company Profile

SymbolCING
Company NameCingulate
Listing DateDec 8, 2021
Issue Price6.00
Founded2012
CEODr. Shane J. Schaffer, Pharm.D.
MarketNASDAQ
Employees13
Fiscal Year Ends12-31
Address1901 West 47th Place
CityKansas City
ProvinceKansas
CountryUnited States of America
Zip Code66205
Phone1-913-942-2300
Websitehttp://www.cingulate.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Shane J. Schaffer, Pharm.D.
  • Chief Executive Officer and Chairman of the Board
  • 770.33K
  • Laurie A. Myers, PhD
  • Executive Vice President and Chief Operating Officer
  • 458.18K
  • Jennifer L. Callahan
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • 446.07K
  • Dr. Raul R. Silva, M.D.
  • Executive Vice President and Chief Science Officer
  • --
  • Dr. Matthew N. Bra M.D.
  • Executive Vice President and Chief Medical Officer
  • --
  • Peter J. Werth
  • Independent Director
  • 47.78K
  • John A. Roberts
  • Independent Director
  • 76.52K
  • Jeffrey S. Ervin
  • Independent Director
  • 72.87K
  • Bryan Lawrence
  • Independent Director
  • 73.92K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
OKAY
833230
+29.96%
CHANGFU CO.,LTD
871396
+24.59%
Gansu Longshenrongfa Pharmaceutical Industry
300534
+20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Trump's comeback to the Office

Following Trump's Policies to Seek Investment Opportunities

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings